Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease
暂无分享,去创建一个
L. Mucke | K. Scearce-Levie | E. Roberson | J. Palop | Tiffany Wu | J. Chin | Gui-qiu Yu | William J. Meilandt | K. Scearce‐Levie
[1] L. Mucke,et al. Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice , 2008, Neurobiology of Aging.
[2] Anatol C. Kreitzer,et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.
[3] L. Mucke,et al. Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.
[4] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[5] L. Mucke,et al. 100 Years and Counting: Prospects for Defeating Alzheimer's Disease , 2006, Science.
[6] L. Mucke,et al. A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.
[7] Yaakov Stern,et al. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.
[8] S. Paul,et al. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. , 2006, The Journal of clinical investigation.
[9] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[10] S. Flitman. Current Pharmacotherapy for Alzheimer ’ s Disease , 2006 .
[11] B. Roques,et al. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors , 2005, Neuroscience.
[12] R. Bodnar,et al. Endogenous opiates and behavior: 2004 , 2005, Peptides.
[13] Bertrand Z. Yeung,et al. Vulnerability of Dentate Granule Cells to Disruption of Arc Expression in Human Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.
[14] L. Mucke,et al. Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[15] L. Stefanacci,et al. Bright light suppresses hyperactivity induced by excitotoxic dorsal hippocampus lesions in the rat. , 2005, Behavioral neuroscience.
[16] M. Bothwell,et al. Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment , 2005 .
[17] Kefei Chen,et al. Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease , 2005, Genes, brain, and behavior.
[18] A. Goate,et al. Mutations in APP have independent effects on Aβ and CTFγ generation , 2004, Neurobiology of Disease.
[19] I. Whishaw,et al. Sequential control of navigation by locale and taxon cues in the Morris water task , 2004, Behavioural Brain Research.
[20] Steven J Novick,et al. Increased seizure threshold and severity in young transgenic CRND8 mice , 2004, Neuroscience Letters.
[21] L. Mucke,et al. Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.
[22] Hui Liu,et al. Effects of chronic administration of PL017 and beta-funaltrexamine hydrochloride on susceptibility of kainic acid-induced seizures in rats. , 2004, Sheng li xue bao : [Acta physiologica Sinica].
[23] S. Schulz,et al. Neuronal types expressing μ‐ and δ‐opioid receptor mRNA in the rat hippocampal formation , 2004 .
[24] K. Stengaard-Pedersen. Comparative mapping of opioid receptors and enkephalin immunoreactive nerve terminals in the rat hippocampus , 1983, Histochemistry.
[25] I. Izquierdo. Effect of naloxone and morphine on various forms of memory in the rat: Possible role of endogenous opiate mechanisms in memory consolidation , 1979, Psychopharmacology.
[26] I. Izquierdo,et al. Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition , 2004, Psychopharmacology.
[27] M. Cherrier,et al. Agnosia for scenes in topographagnosia , 2003, Neuropsychologia.
[28] T. Hökfelt,et al. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23) , 2003, Neurobiology of Disease.
[29] Jacob Raber,et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Zastrow,et al. Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs , 2003, Current Opinion in Neurobiology.
[31] Charles J Duffy,et al. A visuospatial variant of mild cognitive impairment , 2003, Neurology.
[32] H. Chertkow,et al. Visual Retinocortical Function in Dementia of the Alzheimer Type , 2002, Gerontology.
[33] B. Derrick,et al. Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo. , 2002, Journal of neurophysiology.
[34] W Makous,et al. Visual mechanisms of spatial disorientation in Alzheimer's disease. , 2001, Cerebral cortex.
[35] B. Strooper,et al. Pathogenic APP mutations near the γ-secretase cleavage site differentially affect Aβ secretion and APP C-terminal fragment stability , 2001 .
[36] M. Vitek,et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.
[37] Eric J. Simon,et al. μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients , 2001, Brain Research.
[38] J T Williams,et al. Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.
[39] T. Hökfelt,et al. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein — initial observations , 2000, Neuroscience.
[40] T. Sumpter,et al. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. , 2000, Journal of Pharmacology and Experimental Therapeutics.
[41] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[42] C. Drake,et al. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation , 1999, Brain Research.
[43] R. Nicoll,et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Kandel,et al. Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice. , 1998, Learning & memory.
[45] C. Lupica,et al. Opioid Inhibition of Hippocampal Interneurons via Modulation of Potassium and Hyperpolarization-Activated Cation (Ih) Currents , 1998, The Journal of Neuroscience.
[46] M. Wessendorf,et al. Relationship of μ‐ and δ‐opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits , 1998 .
[47] E R Kandel,et al. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[49] D. Johnston,et al. Actions of Endogenous Opioids on NMDA Receptor-Independent Long-Term Potentiation in Area CA3 of the Hippocampus , 1996, The Journal of Neuroscience.
[50] T. Kaneko,et al. Immunohistochemical localization of μ‐opioid receptors in the central nervous system of the rat , 1996, The Journal of comparative neurology.
[51] C. Chavkin,et al. Endogenous opioid regulation of hippocampal function. , 1996, International review of neurobiology.
[52] L. Mucke,et al. Levels and Alternative Splicing of Amyloid β Protein Precursor (APP) Transcripts in Brains of APP Transgenic Mice and Humans with Alzheimer's Disease (*) , 1995, The Journal of Biological Chemistry.
[53] I. Whishaw,et al. Rats with fimbria-fornix lesions display a place response in a swimming pool: a dissociation between getting there and knowing where , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] H. Loh,et al. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[55] Stanley J. Watson,et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.
[56] J. Rinne,et al. Brain methionine- and leucine-enkephalin receptors in patients with dementia , 1993, Neuroscience Letters.
[57] J. L. Martínez,et al. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. , 1992, The Journal of pharmacology and experimental therapeutics.
[58] R. Skelton,et al. Pretraining morphine impairs acquisition and performance in the Morris water maze: Motivation reduction rather than anmesia , 1991, Psychobiology.
[59] C. Chavkin,et al. Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells. , 1991, The Journal of pharmacology and experimental therapeutics.
[60] R. Faull,et al. Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study , 1990, Neuroscience.
[61] R. Cook,et al. Opiate antagonists enhance the working memory of rats in the radial maze , 1990, Pharmacology Biochemistry and Behavior.
[62] V. Höllt,et al. Perforant path kindling induces differential alterations in the mRNA levels coding for prodynorphin and proenkephalin in the rat hippocampus , 1990, Neuroscience Letters.
[63] M. Decker,et al. Effects of naloxone on Morris water maze learning in the rat: enhanced acquisition with pretraining but not posttraining administration , 1989 .
[64] A. Alavi,et al. Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation. , 1989, Ophthalmology.
[65] C. Gall. Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[66] B. Morris,et al. Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Nicoll,et al. Enkephalin hyperpolarizes interneurones in the rat hippocampus. , 1988, The Journal of physiology.
[68] J. McGinty,et al. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors. , 1988, NIDA research monograph.
[69] F. Tortella,et al. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. , 1987, The Journal of pharmacology and experimental therapeutics.
[70] J. Corwin,et al. Naltrexone and Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[71] P. Tariot,et al. Design and interpretation of opiate antagonist trials in dementia , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[72] J. McGinty,et al. Kainic acid alters the metabolism of Met5-enkephalin and the level of dynorphin A in the rat hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[73] M. Gallagher. Effect of β-funaltrexamine on retention of passive-avoidance conditioning , 1985 .
[74] N. Pomara,et al. Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease , 1985, Neurobiology of Aging.
[75] J. L. Martinez,et al. Central versus peripheral actions of Leu-enkephalin on acquisition of a one-way active avoidance response in rats , 1985, Brain Research.
[76] P. Waser,et al. Inhibition of morphine-induced analgesia and locomotor activity in strains of mice: A comparison of long-acting opiate antagonists , 1983, Pharmacology Biochemistry and Behavior.
[77] M. Gallagher,et al. Opiate antagonists improve spatial memory. , 1983, Science.
[78] B. Reisberg,et al. Effects of naloxone in senile dementia: a double-blind trial. , 1983, The New England journal of medicine.
[79] M. Gallagher. Naloxone enhancement of memory processes: effects of other opiate antagonists. , 1982, Behavioral and neural biology.
[80] N. Brecha,et al. Localization of enkephalin‐like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus , 1981, The Journal of comparative neurology.
[81] D. L. Larson,et al. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. , 1981, European journal of pharmacology.
[82] I. Izquierdo,et al. Retrograde amnesia caused by Met- Leu- and des-Tyr-Met-enkephalin in the rat and its reversal by naloxone , 1981, Neuroscience Letters.
[83] T. Duka,et al. Selective localization of different types of opiate receptors in hippocampus as revealed by in vitro autoradiography , 1981, Brain Research.
[84] O. Snead,et al. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. , 1980, Science.
[85] R. Nicoll,et al. Enkephalin blocks inhibitory pathways in the vertebrate CNS , 1980, Nature.
[86] I. Izquierdo,et al. Post-training intraperitoneal administration of leu-enkephalin and beta-endorphin causes retrograde amnesia for two different tasks in rats. , 1980, Behavioral and neural biology.
[87] J. D. McGaugh,et al. Naloxone enhancement of memory. , 1979, Behavioral and neural biology.